The United States Food and Drug Administration (USFDA) has announced the recall of approximately 90,000 bottles of Children’s Ibuprofen Oral Suspension due to potential contamination with foreign material. Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC) issued a public alert following notification of the recall by Strides Pharma Inc.
Key takeaways
- 90,000 bottles of Children’s Ibuprofen Oral Suspension (100 mg/5 mL) recalled in the US
- Strides Pharma Inc. initiated voluntary recall due to foreign material contamination
- NAFDAC advising healthcare providers and parents to check product batches
Contamination Prompts Voluntary Manufacturer Recall
Strides Pharma Inc. initiated a voluntary recall of Children’s Ibuprofen Oral Suspension, USP (100 mg/5 mL) after identifying the presence of foreign material in the pharmaceutical product. The US FDA classified this as a precautionary measure to ensure patient safety.
The affected product is commonly used as a pediatric pain reliever and fever reducer. Healthcare providers have been advised to check their inventory for affected batches and discontinue use of recalled products immediately.
NAFDAC Issues Safety Alert to Nigerian Healthcare System
Nigeria’s NAFDAC received notification of the US recall and issued Public Alert No. 028/2026 to inform local healthcare providers and consumers. While the recall is specific to the United States market, NAFDAC’s alert demonstrates the agency’s commitment to monitoring global pharmaceutical safety issues that could impact Nigerian patients.
The agency emphasized that parents and healthcare providers should verify product sources and report any adverse effects from pediatric medications. This alert is part of NAFDAC’s broader pharmaceutical surveillance system that monitors international drug safety developments.
Foreign material contamination in pediatric medications poses significant safety risks, requiring immediate removal from distribution channels to prevent potential harm to children.
— NAFDAC Public Alert No. 028/2026
What this means
Frequently asked questions
How can parents identify if they have recalled ibuprofen?
Parents should check the manufacturer name (Strides Pharma Inc.) and product details on the label. Contact your pharmacist or healthcare provider if unsure about your specific product batch.
What should I do if my child took the recalled medication?
Monitor your child for any unusual symptoms and contact your healthcare provider immediately if you notice any adverse effects. Most children who received the medication before the recall are unlikely to experience problems.
Are other ibuprofen products affected by this recall?
This recall is specific to Children’s Ibuprofen Oral Suspension, USP (100 mg/5 mL) manufactured by Strides Pharma Inc. Other manufacturers’ ibuprofen products are not affected by this particular recall.
This recall underscores the importance of robust pharmaceutical manufacturing quality control systems, particularly for pediatric medications where safety margins are critical. Healthcare systems worldwide continue to strengthen surveillance mechanisms to rapidly identify and respond to product safety issues, ensuring that contaminated medications are quickly removed from circulation to protect vulnerable pediatric populations.
Was this article helpful?
Related Coverage
